top of page
Prostate Cancer Foundation Canada - Advanced Prostate Cancer
ADVANCED PROSTATE CANCER VIDEO LIBRARY

A selection of videos from the Prostate Cancer Foundation Canada YouTube channel featuring experts from across Canada speaking on new therapies, research, and improving your quality of life while living with advanced prostate cancer.

This video library and its recordings are intended to be a helpful resource to learn more about your disease. Always discuss any treatments or trials with your healthcare provider before trying them.

Introducing the Haven Uro-Oncology Program with Alan Birch
33:59
Harnessing Radioligand Therapy: Innovative Solutions for Advanced Prostate Cancer
40:52
This video is a recording of Prostate Cancer Foundation Canada's May 2024 Coast to Coast Support Group meeting held over Zoom. This is a joint presentation by Dr. Anthony Helou and Dr. Marc-André Morin. Anthony Helou is a leader in the pharmaceutical industry. He was involved in the introduction of important vaccines with Sanofi and Pfizer, including Pfizer-BioNTech's COVID-19 vaccine. He has a Doctor of Pharmacy degree from the University of Florida and is committed to advancing healthcare and pharmaceutical innovation. Dr. Marc-André Morin is a doctor specializing in Nuclear Medicine, practicing at the Center Hospitalier de l’Université de Montréal and at the Center Hospitalier Universitaire de Québec. He also holds a bachelor’s degree in Physiotherapy from McGill University and a Doctorate in Medicine from Laval University. At the same time, he is completing a master's degree in university teaching of health sciences at the University of Montreal. He is also known as the first doctor in Quebec to have infused radioligand treatment for prostate cancer. They are speaking here on Harnessing Radioligand Therappy: Innovative Solutions for Advanced Prostate Cancer. For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.
Why We Should Care About Clinical Trials (And How to Stay in the Loop)
43:51
This video is a recording of Prostate Cancer Foundation Canada's April 2024 Coast to Coast Support Group meeting held over Zoom. Danielle Ralic is the founder and CEO of Ancora.ai, a health tech company that connects cancer patients & their care teams to clinical trials through an AI-powered platform. She studied Finance and Information Systems with a specialty in Healthcare Information Technology at Boston College. She has over 15 years of experience implementing technology solutions in healthcare first with Deloitte in Boston working with hospitals and the public health department, and then at ZS Associates in Los Angeles and Zurich to deliver business intelligence solutions to Top10 Pharma. She is also an accomplished panelist and speaker sharing insights on advanced analytics applications in healthcare. Danielle is speaking here on Why We Should Care About Clinical Trials (And How to Stay in the Loop). For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.
Treatment advances in metastatic prostate cancer - Dr. Edmond Kwan
47:59
This video is a recording of a May 2022 Vancouver Prostate Cancer Support Group meeting. Edmond Kwan, MD, PhD is a UBC Postdoctoral Fellow in the Urologic Sciences Department, working at the Vancouver Prostate Centre. Edmond received his M.D. in 2009 and completed his Medical Oncology Training in Melbourne, Australia in 2017 with a strong interest in the care of patients with genitourinary cancers. He completed his Ph.D. at Monash University in July 2020 focusing on whole blood transcriptomics to identify biomarkers in advanced prostate cancer. His studies were supported by a scholarship from the National Health and Medical Research Council. During his Ph.D., he was actively involved in clinical research as a Principal Investigator and led various local and international clinical trials. In July 2021, supported by a UBC Killam Fellowship, he joined the Wyatt Lab at the Vancouver Prostate Centre to systemically study the genomic landscape of de novo metastatic prostate through the analysis of ctDNA and tumour tissue. --- The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.
Diagnostics and Therapeutics for Prostate Cancer: An Update - Dr. Abby Collier
01:11:29
In honour of Prostate Cancer Awareness Month, Dr. Abby Collier spoke at our Prostate Cancer Awareness Month 2021 Speaker Series. Prostate cancer (PCa) affects Canadian citizens widely and is one of the most common cancers diagnosed in either genders. As time has progressed we have become better at diagnosing and treating PCa. However scientific and medical efforts continue to push the boundaries of diagnosis and therapy. In this presentation Dr Collier will present some of the newly approved diagnostics and therapeutics for PCa, including providing a broad overview of how these fields are developing from a research and clinical trial perspective. About Dr. Collier: Originally from New Zealand, Dr. Collier holds both a BSc and PhD in pharmacology from the University of Auckland. After a postdoctoral fellowship with Professor Chris Pritsos at the University of Nevada, Dr. Collier was an assistant professor, then associate professor at the University of Hawaii Medical School. A member of the Faculty of Pharmaceutical Sciences at UBC since 2013, Dr. Collier is professor of Drug Metabolism and Pharmacokinetics, teaches pharmacology to undergraduate, graduate, pharmacy and medical students, maintains an active and well-funded research lab and directs the new undergraduate BPSc degree program. Dr. Collier's sub-specialty is drug metabolism and pharmacokinetics. She is the winner of the 2021 Center for Alternatives to Animal Testing (CAAT) Award (biennial, world-wide) in recognition of her scientific research leading the field in modeling and simulation “to reduce, refine and replace animal use”. She uses a combination of laboratory work and computer modeling to improve drug/chemical safety and efficacy. Along with her collaborators, she also performs research and publishes regularly in the fields of human and environmental toxicology and endocrinology, including prostate cancer. --- The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of the Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.
PSMA PET-CT Imaging: A Patient Perspective
01:16:36
In honour of Prostate Cancer Awareness Month, Dr. Phil Cohen, MD, FRCP(C), ABNM, joined our Coast to Coast Prostate Cancer Support Group Meeting as part of our Prostate Cancer Awareness Speaker Series. --- About Dr. Cohen: Dr. Philip Cohen is the Division Head of Nuclear Medicine at Lions Gate Hospital in Vancouver, Canada. He is the past chairman of the Diagnostic Accreditation Subcommittee for Nuclear Medicine of the British Columbia (B.C.) Medical Association and the B.C. College of Physicians, Member-at-Large of the Canadian Association of Nuclear Medicine, and Clinical Professor at the University of B.C. Dr Cohan has numerous publications and is a member of the editorial board of the Iranian Journal of Nuclear Medicine. He is a Fellow of the Royal College of Physicians and Surgeons of Canada in Nuclear Medicine, and also of the American Board of Nuclear Medicine. Dr. Cohen is a pioneer in Nuclear Medicine in Canada and in the usage of 3-D imaging techniques to improve diagnosis of bone disease and injury in collaboration with the Medical Imaging Research Group at University of British Columbia. Dr Cohen has been involved in clinical research trials of new radiopharmaceuticals. To that effect, he was the first recipient of a research grant from the Lions Gate Hospital Foundation, one of several peer-reviewed awards that would follow. --- The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.
New Developments in Radiopharmaceutical Imaging and Therapy of Prostate Cancer - Dr. Arman Rahmim
01:20:10
This video is a recording of the Coast to Coast Nationwide Prostate Cancer Support Group's July 2021 meeting held over Zoom. About Arman Rahmim, PhD, DABSNM: Dr. Rahmim is Associate Professor of Radiology and Physics at the University of British Columbia (UBC) as well as Senior Scientist and Provincial Medical Imaging Physicist at BC Cancer. He received his MSc in condensed matter physics and PhD in medical imaging physics at UBC. Following doctoral studies, he was recruited by Johns Hopkins University (JHU) to lead the high resolution brain PET imaging physics program and to pursue research at the JHU Department of Radiology. In 2018, he was recruited back to Vancouver, where he conducts research in tomographic image generation and analysis, including oncologic and brain applications. He has published a book and over 150 journal articles and 300 conference proceeding papers/abstracts, and has delivered more than 100 invited lectures worldwide. He has participated as principal investigator or co-investigator on a range of grants towards quantitative tomographic imaging, including translation to clinical applications. For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), please visit www.prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.
bottom of page